Lincocin

Lincomycin, the active ingredient in Lincocin, is a lincosamide presented as an oral dosage form for systemic use. It treats bacterial infections caused by susceptible organisms and is prescribed for a range of Gram‑positive and anaerobic infections.

GNH USA supplies Lincocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑controlled batches, reliable logistics across EU and global markets, and providing full regulatory documentation for import and distribution.

Lincocin (lincomycin) is used to treat bacterial infections in which the causative organisms are susceptible to lincosamides. - Skin and soft tissue infections: effective against Staphylococcus aureus and Streptococcus species, reducing infection severity. - Bone and joint infections: used for osteomyelitis and septic arthritis caused by susceptible anaerobic bacteria. - Respiratory tract infections: treats pneumonia and bronchitis where anaerobic pathogens are involved. - Intra‑abdominal infections: employed for peritonitis and intra‑abdominal abscesses caused by susceptible organisms.

Lincomycin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Rash: mild skin erythema or itching. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis: severe diarrhea and colitis. - Anaphylaxis: acute allergic reaction with hives, swelling, and respiratory distress. - Hepatotoxicity: significant liver injury indicated by jaundice or marked enzyme elevation.

When prescribing Lincocin, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust therapy or monitor renal function in patients with reduced kidney function. - Hepatic dysfunction: use cautiously and monitor liver enzymes in patients with liver disease. - Concomitant ototoxic drugs: avoid or monitor when used with aminoglycosides or loop diuretics. - Pregnancy: assess risk‑benefit ratio as safety data are limited. - Allergic history: discontinue if signs of hypersensitivity such as rash or swelling appear. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct sunlight.

Lincomycin can interact with other medicines, affecting its efficacy or increasing toxicity.

Major Interactions (Avoid): - Erythromycin: combined use may increase risk of hepatotoxicity. - Neuromuscular blocking agents: may potentiate muscle weakness.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect; monitor INR. - Oral contraceptives: may reduce contraceptive effectiveness; advise additional contraception. - Probenecid: may increase lincomycin plasma levels; adjust dose if necessary.